Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation.

Baker AW, Lewis SS, Alexander BD, Chen LF, Wallace RJ Jr, Brown-Elliott BA, Isaacs PJ, Pickett LC, Patel CB, Smith PK, Reynolds JM, Engel J, Wolfe CR, Milano CA, Schroder JN, Davis RD, Hartwig MG, Stout JE, Strittholt N, Maziarz EK, Saullo JH, Hazen KC, Walczak RJ Jr, Vasireddy R, Vasireddy S, McKnight CM, Anderson DJ, Sexton DJ.

Clin Infect Dis. 2017 Apr 1;64(7):902-911. doi: 10.1093/cid/ciw877.

2.

Cardiopulmonary Bypass Strategy for a Cyanotic Child With Hemoglobin SC Disease.

Machovec KA, Jaquiss RD, Kaemmer DD, Ames WA, Homi HM, Walczak RJ Jr, Lodge AJ, Jooste EH.

Ann Thorac Surg. 2016 Jun;101(6):2373-5. doi: 10.1016/j.athoracsur.2015.09.046.

PMID:
27211949
3.

A change in anticoagulation monitoring improves safety, reduces transfusion, and reduces costs in infants on cardiopulmonary bypass.

Machovec KA, Jooste EH, Walczak RJ, Homi HM, Jaquiss RD, Lodge AJ, Ames WA.

Paediatr Anaesth. 2015 Jun;25(6):580-6. doi: 10.1111/pan.12591. Epub 2014 Dec 21.

PMID:
25530420
4.

Circuit oxygenator contributes to extracorporeal membrane oxygenation-induced hemolysis.

Williams DC, Turi JL, Hornik CP, Bonadonna DK, Williford WL, Walczak RJ, Watt KM, Cheifetz IM.

ASAIO J. 2015 Mar-Apr;61(2):190-5. doi: 10.1097/MAT.0000000000000173.

5.

Bridge to transplant with extracorporeal membrane oxygenation followed by HeartWare ventricular assist device in a child.

Crews KA, Kaiser SL, Walczak RJ, Jaquiss RD, Lodge AJ.

Ann Thorac Surg. 2013 May;95(5):1780-2. doi: 10.1016/j.athoracsur.2012.09.088.

PMID:
23608259
6.

Active rehabilitation during extracorporeal membrane oxygenation as a bridge to lung transplantation.

Rehder KJ, Turner DA, Hartwig MG, Williford WL, Bonadonna D, Walczak RJ Jr, Davis RD, Zaas D, Cheifetz IM.

Respir Care. 2013 Aug;58(8):1291-8. doi: 10.4187/respcare.02155. Epub 2012 Dec 4.

7.

State of the art: strategies for extracorporeal membrane oxygenation in respiratory failure.

Rehder KJ, Turner DA, Bonadonna D, Walczak RJ Jr, Cheifetz IM.

Expert Rev Respir Med. 2012 Nov;6(5):513-21. doi: 10.1586/ers.12.55. Review.

PMID:
23134246
8.

Technological advances in extracorporeal membrane oxygenation for respiratory failure.

Rehder KJ, Turner DA, Bonadonna D, Walczak RJ, Rudder RJ, Cheifetz IM.

Expert Rev Respir Med. 2012 Aug;6(4):377-84. doi: 10.1586/ers.12.31.

PMID:
22971063
9.

Development of a collaborative program to provide extracorporeal membrane oxygenation for adults with refractory hypoxemia within the framework of a pandemic.

Turner DA, Williford WL, Peters MA, Thalman JJ, Shearer IR, Walczak RJ Jr, Griffis M, Olson SA, Sowers KW, Govert JA, Macintyre NR, Cheifetz IM.

Pediatr Crit Care Med. 2011 Jul;12(4):426-30. doi: 10.1097/PCC.0b013e3181ff41c1.

PMID:
21057349
10.

Controlled-release microchips.

Sharma S, Nijdam AJ, Sinha PM, Walczak RJ, Liu X, Cheng MM, Ferrari M.

Expert Opin Drug Deliv. 2006 May;3(3):379-94. Review.

PMID:
16640498
11.

Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers.

Foraker AB, Walczak RJ, Cohen MH, Boiarski TA, Grove CF, Swaan PW.

Pharm Res. 2003 Jan;20(1):110-6.

PMID:
12608544
13.
14.

Nonactin biosynthesis: the potential nonactin biosynthesis gene cluster contains type II polyketide synthase-like genes.

Walczak RJ, Woo AJ, Strohl WR, Priestley ND.

FEMS Microbiol Lett. 2000 Feb 1;183(1):171-5.

Supplemental Content

Loading ...
Support Center